A genetic disease is caused by the abnormal expression of one of more sgenes. These conditions can be caused by a number of possible pathways: genetic mutation, abnormal chromosome number, incorrect gene sequencing, and defective genes. Currently there are about 4,000 known genetic disorders, with new ones discovered every year. The vast majorities of the disorders are quite rare, and affect only one out of several thousand or million people. Cystic fibrosis is the most common genetic disorder, with approximately 5 percent of the U.S. population carrying a copy of the defective gene.

Chronic Granulomatous Disease (CGD)

Chronic granulomatous disease is a diverse group of hereditary disease in which immune system cells have difficulty forming reactive oxygen compounds necessary to kill ingested pathogens. The incidence of chronic granulomatous disease is about 1 in a million.

Company Product Phase  
InterMune Inc Actimmune M Chronic Granulomatous Disease

Mucopolysaccaridoses

The mucopolysaccharidoses are a group of inherited diseases in which a defective or missing enzyme causes large amounts of complex sugar molecules to accumulate in harmful amounts in the body's cells and tissues. This accumulation causes permanent, progressive cellular damage that affects appearance, physical abilities, organ and system functioning, and, in most cases, mental development. Depending on the type of mucopolysaccharidosis, affected individuals may have normal intellect or may be profoundly retarded, may experience developmental delay, or have severe behavioral problems. Physical symptoms generally include coarse or rough facial features, thick lips, an enlarged mouth and tongue, short stature with a disproportionately short trunk (dwarfism), abnormal bone size or shape (and other skeletal irregularities), thickened skin, enlarged organs such as the liver or spleen, hernias, and excessive body hair growth. It is estimated that one in every 25,000 babies born in the United States will have some form of the mucopolysaccharidoses.

Company Product Phase  
BioMarin Pharmaceutical Inc Aldurazyme PM Mucopolysaccharidosis-I
BioMarin Pharmaceutical Inc Naglazyme M Mucopolysaccharidosis-VI